3rd HF Drug Discovery & Development Summit

R&D

This 3rd HF Drug Discovery & Development Summit stands as the hub of knowledge, showcasing the latest in developments in the preclinical heart failure drug development. Together with 50+ experts, immerse yourself and your team in cutting edge cardiac drug development from discovery to target validation.

Elevate your understanding of precision approaches to heart failure with Bayer & Tenaya
Unearth developments in accelerating the translatability for heart failure disease modelling with Pfizer & Novo Nordisk
Stay ahead of the curve on developments in the intersection of aging biology and heart failure with Regeneron
Delve into novel biology from non-coding RNAs to gene therapy and small molecules with LEXEO, Cytokinetics & Cardior
Increase your understanding on optimal stratification of heart failure with Novartis
And so much more...